Albert David Ltd.

Financial

	Albert David	Medicamen Biotech	Brooks Laboratories
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.84 %	n/a	n/a
Financials
5 yr Average ROE	11.47 %	8.49 %	-23.88 %
5yr average Equity Multiplier	1.63	1.47	1.78
5yr Average Asset Turnover Ratio	0.62	0.58	0.6
5yr Avg Net Profit Margin	11.31 %	10.0 %	-23.79 %
Price to Book	1.19	2.26	4.6
P/E	74.08	50.58	0.0
5yr Avg Cash Conversion Cycle	-77.77 Days	13.14 Days	-10.34 Days
Inventory Days	47.91 Days	66.66 Days	93.5 Days
Days Receivable	27.87 Days	122.66 Days	66.75 Days
Days Payable	140.35 Days	257.34 Days	179.8 Days
5yr Average Interest Coverage Ratio	93.73	10.36	-11.84
5yr Avg ROCE	14.69 %	12.12 %	-15.03 %
5yr Avg Operating Profit Margin	9.55 %	16.84 %	-13.23 %
5 yr average Debt to Equity	0.02	0.14	0.21
5yr CAGR Net Profit	-4.92 %	-6.51 %	0.22 %
5yr Average Return on Assets	7.03 %	5.75 %	-14.62 %
Shareholdings
Promoter Holding	62.24 %	40.46 %	52.62 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.25 %	-3.14 %	-13.79 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	9.9 %

Business

	Albert David	Medicamen Biotech	Brooks Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals Formulations 0	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Pharmaceutical 0	Product Wise Break-Up Pharmaceuticals Formulations 0 Pharmaceutical 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 93.24 Rest of the World 6.76	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0	-
Dosage Form Break-Up	Dosage Form Break-Up LVP – Large volume Parenteral 27.91 Syrup 21.16 Tablet 15.97 SVP – Small volume Parenteral 14.95 Capsule 9.65 Ointment 9.06 Others 1.3	-	-
Customer Wise Break-Up	Customer Wise Break-Up Non Government 98.36 Government 1.64	-	-